Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $56,162 - $67,779
-339 Reduced 5.01%
6,426 $1.09 Million
Q4 2023

Jan 30, 2024

BUY
$151.44 - $200.09 $81,474 - $107,648
538 Added 8.64%
6,765 $1.34 Million
Q3 2023

Oct 11, 2023

BUY
$167.14 - $192.77 $1.04 Million - $1.2 Million
6,227 New
6,227 $1.08 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Goodman Advisory Group, LLC Portfolio

Follow Goodman Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goodman Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goodman Advisory Group, LLC with notifications on news.